OCUP लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:55):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders...

Stats
आज की मात्रा	32 757
औसत मात्रा	187 146
बाजार मूल्य	40.44M
EPS	$-0.290 ( Q1 \| 2024-03-31 )
अगली कमाई की तारीख	( $-0.290 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.32 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00700 (0.45%)

AADI -2.65%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 3.07%

ABUS -2.29%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.12%

ACGN 1.29%

ACHL -3.00%

ACHV -1.72%

ACIU -1.00%

ACLX -0.04%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.06%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.46%

AKRO -2.89%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.19%

ALLK -9.32%

ALLO -6.24%

ALLR -3.32%

ALNA 3.16%

ALNY 1.81%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.58%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.92%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.07%

APLT -5.41%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.75%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.63%

ARWR -1.64%

ASLN -5.02%

ASMB -7.14%

ASND -0.94%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.40%

ATRA -3.22%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA 1.17%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.83%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.94%

BCAB 1.95%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.32%

BCTX 7.65%

BCTXW -16.32%

BCYC 1.10%

BDRX -3.52%

BDTX -0.64%

BEAM 0.49%

BFRA -2.91%

BGNE -2.72%

BIOR -3.40%

BIVI 2.50%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.71%

BMEA -9.84%

BMRN 0.34%

BNOX -2.22%

BNTC -2.11%

BNTX -1.55%

BOLD -7.90%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.31%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL -1.05%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.89%

CCCC -5.22%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 5.52%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.50%

CGEN -3.31%

CGON -0.48%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.26%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.44%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.83%

CORT 2.20%

COYA -1.46%

CPRX -0.99%

CRBP -1.88%

CRBU -5.10%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.86%

CRSP 0.95%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 2.03%

CUE 3.53%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.08%

CYTO -2.73%

DARE 6.41%

DAWN 0.75%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 31.70%

DNLI -1.70%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.98%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.03%

EXAI -0.57%

EXEL -0.40%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -7.80%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.64%

FENC -0.97%

FGEN -5.53%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.68%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.89%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.00%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.85%

GOVX 5.93%

GOVXW -49.04%

GPCR -6.49%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.14%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.38%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.46%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -4.12%

ICCC 0.22%

ICPT 0.21%

ICU 16.48%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.94%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.70%

INAB 0.00%

INBX 0.46%

INCY -0.84%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 3.01%

INO -2.20%

INSM -0.81%

INTS -2.75%

INVA 0.25%

INZY 0.92%

IOBT -11.42%

IONS 0.34%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.02%

JAZZ -0.74%

JNCE 0.00%

JSPR -6.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.84%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 18.47%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.52%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.60%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -4.05%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.80%

LYRA 2.33%

MACK 0.10%

MBIO -9.29%

MBRX -1.72%

MCRB 1.76%

MDGL -2.52%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.54%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.79%

MNKD -1.14%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.18%

MORF -3.77%

MREO -6.14%

MRKR 2.68%

MRNA -4.80%

MRNS -4.04%

MRSN -2.40%

MRTX -0.17%

MRUS 0.13%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -0.91%

NMTR -42.97%

NOVN -24.84%

NRBO 10.16%

NRIX -0.34%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.28%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -2.49%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.29%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.54%

OMER -1.03%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.43%

PDSB -2.53%

PEPG 0.27%

PGEN -3.03%

PHAR 1.51%

PHAS 0.00%

PHAT -1.07%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.95%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.10%

RCKT -7.81%

REGN -0.70%

RENB -3.42%

REPL -2.60%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.44%

RIGL -3.28%

RLAY -4.68%

RLMD 0.33%

RLYB -0.34%

RNA -0.58%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.12%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.00%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 2.35%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.46%

RYTM -6.51%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.31%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.38%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.05%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -2.99%

SNDX 0.87%

SNGX -4.52%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.45%

SRRA 0.00%

SRRK -2.79%

SRZN -2.45%

STAB 0.00%

STOK -5.09%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX 0.22%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.57%

TARS 0.06%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.15%

TENX -1.27%

TERN -7.72%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.16%

TNXP -6.39%

TNYA -7.18%

TPST 2.87%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -2.93%

TTNP -9.27%

TVTX 0.63%

TYRA -7.01%

UBX -2.12%

UNCY -2.43%

URGN -0.85%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 106.32%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.74%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.43%

VIRI -1.57%

VIRX 2.40%

VKTX -1.67%

VLON -13.04%

VNDA -2.20%

VOR -2.01%

VRCA -0.07%

VRDN -4.23%

VRNA -1.40%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.90%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.81%

XERS 2.86%

XFOR 2.09%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-11	Rodgers Richard J	Buy	41 143	Common Stock
2024-06-11	Rodgers Richard J	Buy	35 181	Stock Option (Right to Buy)
2024-06-11	Pepose Jay	Buy	41 143	Common Stock
2024-06-11	Pepose Jay	Buy	35 181	Stock Option (Right to Buy)
2024-06-11	Manuso James S J	Buy	41 143	Common Stock

INSIDER POWER
96.19
Last 94 transactions
Buy: 4 001 388 \| Sell: 115 125

सहसंबंध (AI algo v.1.1b): Undervalued: 0.01% $1.560 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.12 (neutral)

छोटा: -0.51 (weak negative)

Signal:(56.999) Neutral

Ocuphire Pharma, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Ocuphire Pharma, Inc. सहसंबंध - मुद्रा/वस्त्र

0.43
( neutral )

0.76
( moderate )

0.00
( neutral )

0.73
( moderate )

Ocuphire Pharma, Inc. वित्तीय

Annual	2023
राजस्व:	$19.05M
सकल लाभ:	$19.04M (99.97 %)
EPS:	$-0.460

FY	2023
राजस्व:	$19.05M
सकल लाभ:	$19.04M (99.97 %)
EPS:	$-0.460

FY	2022
राजस्व:	$39.85M
सकल लाभ:	$39.85M (99.99 %)
EPS:	$0.900

FY	2021
राजस्व:	$589 000
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-3.82

Financial Reports:

No articles found.

Ocuphire Pharma, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.